114 related articles for article (PubMed ID: 17119875)
1. CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure.
Imai M; Rastogi S; Sharma N; Chandler MP; Sharov VG; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):9-15. PubMed ID: 17119875
[TBL] [Abstract][Full Text] [Related]
2. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
Sabbah HN; Chandler MP; Mishima T; Suzuki G; Chaudhry P; Nass O; Biesiadecki BJ; Blackburn B; Wolff A; Stanley WC
J Card Fail; 2002 Dec; 8(6):416-22. PubMed ID: 12528095
[TBL] [Abstract][Full Text] [Related]
4. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
Wu L; Belardinelli L; Fraser H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):372-9. PubMed ID: 18427280
[TBL] [Abstract][Full Text] [Related]
5. Acute intravenous infusion of an adenosine regulating agent improves left ventricular function in dogs with advanced heart failure.
Wang M; Gupta RC; Rastogi S; Kohli S; Zhang K; Lanfear DE; Sabbah HN
Cardiovasc Drugs Ther; 2013 Dec; 27(6):489-98. PubMed ID: 23907235
[TBL] [Abstract][Full Text] [Related]
6. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
[TBL] [Abstract][Full Text] [Related]
7. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
Chandler MP; Stanley WC; Morita H; Suzuki G; Roth BA; Blackburn B; Wolff A; Sabbah HN
Circ Res; 2002 Aug; 91(4):278-80. PubMed ID: 12193459
[TBL] [Abstract][Full Text] [Related]
9. Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.
Bakkehaug JP; Kildal AB; Engstad ET; Boardman N; Næsheim T; Rønning L; Aasum E; Larsen TS; Myrmel T; How OJ
Circ Heart Fail; 2015 Jul; 8(4):766-75. PubMed ID: 26025342
[TBL] [Abstract][Full Text] [Related]
10. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
[TBL] [Abstract][Full Text] [Related]
11. Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure.
Liu Y; Yue WS; Liao SY; Zhang Y; Au KW; Shuto C; Hata C; Park E; Chen P; Siu CW; Tse HF
J Cardiovasc Electrophysiol; 2012 May; 23(5):534-40. PubMed ID: 22151312
[TBL] [Abstract][Full Text] [Related]
12. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
13. Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure.
Gupta RC; Mishra S; Mishima T; Goldstein S; Sabbah HN
J Mol Cell Cardiol; 1999 Jul; 31(7):1381-9. PubMed ID: 10403755
[TBL] [Abstract][Full Text] [Related]
14. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
[TBL] [Abstract][Full Text] [Related]
15. Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
Shen YT; Malik FI; Zhao X; Depre C; Dhar SK; Abarzúa P; Morgans DJ; Vatner SF
Circ Heart Fail; 2010 Jul; 3(4):522-7. PubMed ID: 20498236
[TBL] [Abstract][Full Text] [Related]
16. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M
Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985
[TBL] [Abstract][Full Text] [Related]
17. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
18. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
19. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
Bersin RM; Wolfe C; Kwasman M; Lau D; Klinski C; Tanaka K; Khorrami P; Henderson GN; de Marco T; Chatterjee K
J Am Coll Cardiol; 1994 Jun; 23(7):1617-24. PubMed ID: 8195522
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
Santos-Gallego CG; Requena-Ibanez JA; San Antonio R; Ishikawa K; Watanabe S; Picatoste B; Flores E; Garcia-Ropero A; Sanz J; Hajjar RJ; Fuster V; Badimon JJ
J Am Coll Cardiol; 2019 Apr; 73(15):1931-1944. PubMed ID: 30999996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
